Drug delivery and manufacturing Posters

MONDAY 25 SEPTEMBER

DDD-001 Development and stability evaluation of a hydrophilic gel containing a coenzyme Q10-loaded nanoemulsion
Ms Jelena Đorđić1, Nina Dragićević1
1Department of Pharmacy, Singidunum University, Belgrade, Serbia

DDD-002 Development of hydrophilic gel containing methanol extract of Cotinus coggygria stem with bark
Nina Dragićević1, Ms Jelena Đorđić1, Jelena Zivkovic1
1Institute “Dr Josif Pancic”, Belgrade, Serbia

DDD-003 Harnessing the synergistic potential of 3D printed buccal films and nanostructured lipid carriers (NLCs) for personalised cannabidiol delivery
Mr Sadikalmahdi Abdella1, Mr Sangseo Kim1, Dr Franklin Afinjuomo1, Ms Souha Youssef1, Dr Yunmie Song1, Professor Richard Upton1, Professor Sanjay Garg
1Centre for Pharmaceutical Innovation (CPI), Clinical and Health Sciences, University of South Australia, Adelaide, SA 5000, Australia, , Australia

DDD-004 pH-responsive Inulin Hydrogel Loaded with 5-FU for Colon Target Delivery
Dr Franklin Afinjuomo1
1University Of South Australia, Adelaide , Australia

DDD-005 Spray-drying technique retains the alpha-glucosidase inhibitory activity of ethnopharmacological plants
Dr Florencio Jr Arce1, Dr Gerard Lee See1, Dr Jonie Yee2, Ms Meije Lapinig3, Mr Glenn Joseph Ecoy3, Ms Queenie Marie Maquilang4, Ms Angel Lyn Kristin Tan4, Dr Patrick John Lim4
1Pharmaceutical Research and Drug Development Laboratories, Department of Pharmacy, School of Health Care Professions, University of San Carlos, Cebu, Philippines, 2Applied Microbiology and Molecular Biology Laboratory, Department of Biology, School of Arts and Sciences, University of San Carlos, Cebu, Philippines, 3Tuklas Lunas Development Center, University of San Carlos, Cebu, Philippines, 4Tuklas Lunas Development Center/Department of Chemistry, School of Arts and Sciences, University of San Carlos, Cebu, Philippines

DDD-006 Formulation and characterization of niosomal gel for topical delivery of ceftazidime against staphylococcus aureus and methicillin resistant staphylococcus aureus
Ms Alexandra Diloy Atienza1,2, Dr Gerard De Guzman1
1Adamson University Manila, Manila, Philippines, 2Centro Escolar University, Manila, Philippines, 3Department of Pharmacology & Toxicology, College of Medicine, University of the Philippines, Manila, Philippines

DDD-007 Controlling the development of short-sightedness in children using atropine loaded contact lenses
Mr Md Abdullah Aziz1, Dr. Furqan Maulvi, Professor Mark Willcox
1School of Optometry and Vision Science, University of New South Wales, Sydney, NSW, Australia, Sydney, Australia

DDD-008 Influence of lung fluid protein types on in vitro dissolution and absorption of an inhalable drug
Mr Rakesh Bastola1, Professor Paul M. Young2, Dr Shyamal Das1
1School of Pharmacy, University Of Otago, Dunedin, New Zealand, 2Macquarie Business School, Macquarie University, Sydney, Australia

DDD-009 Evidence-based quality scores for rating drug products
Dr Arash Dabestani1, Dr David Light, Dr Kenny Yu
1LIU Pharmacy (Arnold & Marie Schwartz College of Pharmacy and Health Sciences), Brooklyn, United States

DDD-010 Microemulsion based intravaginal gel for polycystic ovarian syndrome
Dr Rajeshri Kasinath Dhurke1, Mrs Manusri Naredla1, Dr Praveen Devanandan1, Dr Ranadheer Chowdhary Puvvada1
1St. Peter’s Institute of Pharmaceutical Sciences, Warangal, Telangana, India

DDD-011 Developing advanced lipid-based oral delivery formulations for treating luekemia
Ms Yukta Hegishte1, Dr Paul Joyce1, Dr Clive Prestidge1, Dr Kristen Bremmell1
1Centre for Pharmaceutical Innovation, Adelaide, Australia

DDD-012 Bioresorbable delayed release implant for livestock immunisation
Mr Norman Ilich1,2, Dr Enoch Chan3, Prof Tim Dargaville1,2
1Australian Research Council Training Centre for Cell and Tissue Engineering Technologies , Brisbane, Australia, 2Centre for Materials Science, School of Chemistry & Physics, Faculty of Science, Queensland University of Technology (QUT), Brisbane, Australia, 3School of Clinical Sciences, Discipline of Pharmacy, Faculty of Health, Queensland University of Technology (QUT), Brisbane, Australia

DDD-013 Novelty of quantum dots as a drug delivery vehicle design for nanoparticle
Dr Jamshaid Iqbal1, Dr Khurram Iqbal2, Dr Iqra Kashif3, Chemist Rabiya Ijaz4, Dr Shahbaz Ahmed5
1University of Agriculture Faisalabad, Faisalabad, Pakistan, 2Government College University Faisalabad, Faisalabad, Pakistan, 3Government College University Faisalabad, Faisalabad, Pakistan, 4Government College University Faisalabad, Faisalabad, Pakistan, 5University of Agriculture Faisalabad, Faisalabad, Pakistan

DDD-014 Atractylodes lancea Rhizome-derived Exosome-like
Nanoparticles Suppress Lipopolysaccharide-induced
Inflammation by Murine Microglial Cells
博士 Kei Kawada1,2, Dr. Tomoaki Ishida3, Dr. Shumpei Morisawa3, Dr. Kohei Jobu3, Dr. Fuka Aizawa1, Kenta Yagi1, Dr Yuki Izawa-Ishizawa1, Dr. Takahiro Niimura1, Dr. Shinji Abe2, Dr. Mitsuhiro Goda1, Professor Keisuke Ishizawa1
1Department of Clinical Pharmacology and Therapeutics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan, 2Graduate School of Pharmaceutical Sciences, Tokushima University, Tokushima, Japan, 3Department of Pharmacy, Kochi Medical School Hospital, Kochi, Japan

DDD-015 Optimization of the ultrasound-assisted extraction process for the purification of phosphatidylcholine from rice bran lecithin using Box-Behnken response surface methodology and analysis of rice bran phosphatidylcholine emulsifying property
Ms Surathanan Kongwan1, Assistant Professor Dr. Chittima Managit1, Associate Professor Dr. Worapan Sitthithaworn1
1Faculty Of Pharmacy, Srinakharinwirot University, Nakhonnayok, Thailand

DDD-016 Impact of different apolipoprotein E isoforms on the in-vitro expression and function of P-glycoprotein at the blood-brain barrier
Mr Ethan Kreutzer1, A/Prof. Jennifer Short1, Dr Joe Nicolazzo1
1Monash University, Melbourne, Australia

TUESDAY 26 SEPTEMBER

DDD-020 Assessing the in vitro dissolution rate of metformin from different commercially available tablets using distinct physiological pH media at different fast/fed states
Dr Ayman Allahham1
1Rmit University, Bundoora, Australia

DDD-021 Impact of vinification techniques on antioxidant activity of fermented grape pomace
Mr Uroš Čakar1, Mrs Nikolina Živković2, Mrs Ivana Plavšić-Janjatović2, Mr Aleksandar Petrović2, Mrs Ljiljana Gojković-Bukarica3
1Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia, 2Faculty of Agriculture, University of Belgrade, Belgrade, Serbia, 3Faculty of Medicine, University of Belgrade, Belgrade, Serbia

DDD-022 Preclinical development of an injectable Multipurpose Prevention Technology (MPT) formulation for contraception and HIV prevention
Dr Clement Haeck1,2, Dr Peter Boyd1, Dr Nastasia Dimant3, Dr Aurélie Barrail-Tran3, Ms. Hélène Gouget3, Prof. Roger Le Grand3, Dr Delphine Desjardins3, Prof. Karl Malcolm1
1School of Pharmacy, Queen’s University Belfast, Belfast, United Kingdom, 2Center for Biomedical Research, Population Council, New York, United States, 3Université Paris-Saclay, INSERM, CEA, Immunology of Viral, Autoimmune, Hematological and Bacterial Diseases, Fontenay-aux-Roses & Le Kremlin-Bicêtre, France

DDD-023 Characterization and evaluation of tablets prepared from different native starches
Mr Shiv Kumar1
1Maharaja Ranjit Singh Punjab Technical University, Bathinda, India

DDD-024 An inhalable hybrid biomimetic nanoplatform for on-demand drug release and modulating lung microenvironment in acute lung injury treatment
Ms Chang Liu1, Prof Ying Zheng1
1University Of Macau, Macao, China

DDD-025 Injectable microparticle for the sustained release of Aripiprazole: formulation design and pharmacokinetic assessment
Ms Min-Yun Liu1, Ms Xiu-Jin Peng1, Dr Chien-Ming Hsieh1
1Taipei Medical University, College of Pharmacy, Taipei City, Taiwan China

DDD-026 Development of abemaciclib-loaded solid lipid nanoparticles using quality-by-design approach and evaluation of its anticancer activity in MDA-MB-231 and T47D breast cancer cells
Ms Bonnie Chin1, Dr Wei Meng Lim2, Dr Thiagarajan Madheswaran3
1School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia, 2School of Pharmacy, Monash University, Kuala Lumpur, Malaysia, 3Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia

DDD-027 Evaluation of the cytotoxic effect and wound healing property of chrysin and its incorporation in nanofiber mat
Assistant Professor Dr. Chittima Managit1, Ms Buntita Naktabtee1, Ms Supitcha Hansurabhanont1, Associate Professor Dr. Chuda Chittasupho2
1Faculty of Pharmacy, Srinakharinwirot University, Nakhonnayok, Thailand, 2Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand

DDD-028 Unlocking the potential of cannabidiol: Preliminary findings on the benefits of a phospholipid complex
Ms Thabata Muta1, Dr Franklin Afinjuomo1, Dr Yunmei Song1, Professor Sanjay Garg1
1University of South Australia, Adelaide, Australia

DDD-029 A shot at a better life: Long-acting injectable for Parkinson’s disease
Ms Deepa Nakmode1, Dr Franklin Afinjuomo1, Dr Yunmei Song1, Professor Sanjay Garg1
1University of South Australia, adelaide, Australia

DDD-030 Reviewing the effects of Monoclonal antibody formulations, with relevance to Rheumatoid Arthritis
Ms Yamunna Narayanan1, Dr Amal Elkordy
1University of Sunderland, Sunderland, United Kingdom

DDD-031 PharmBCS: a Biopharmaceutical Classification System (BCS) classification prediction web-platform based on advanced machine learning algorithms with multiple molecular representations
Mr Zheng Wu1, Prof Defang Ouyang1, Prof Defang Ouyang1
1University Of Macau, Macau, Macau SAR China

DDD-032 Aloe vera blended alginate-gelatin composite hydro film for diabetic wound healing application
Dr Jithendra Panneerselvam1, Dr Sasikala Chinnappan2, Ms Pirya Darsni Thangamani1, Mr Yong Seng Lim1
1Department of Pharmaceutical Technology, International Medical University, Kuala Lumpur, Malaysia, 2Department of Pharmaceutical biology Faculty of Pharmaceutical Sciences, UCSI University, Cheras, Kuala Lumpur, Malaysia

DDD-033 Female-controlled non-hormonal contraceptive for on-demand prevention of pregnancies and sexually transmitted infections
Ms Riya Patel1, Dr. Burcu Uner1, Prof Giovanni Pauletti1
1University Of Health Sciences & Pharmacy In St. Louis, Saint Louis, MO, United States

DDD-034 Encapsulation of lutein extracted from Gac in lipid based nanocarriers for eye health
Ms Dao Nguyen2, Dr Thilini Thrimawithana1, Associate Professor Terry Piva1, Professor Charlotte Conn2, Associate Professor Tien Huynh2
1School of Health and Biomedical Sciences, RMIT University, Melbourne, Australia, 2School of Science, RMIT University, Melbourne, Australia

DDD-035 IN VIVO ANTI-INFLAMMATORY ACTIVITY IN BLEOMYCIN-INDUCED RATS OF QUERCETIN LOADED MICROSPHERES: EFFECT OF ALGINATE CONCENTRATIONS
Ms Iqlima Prestisya1, Dr Andang Miatmoko1, Prof Dewi Melani Hariyadi1
1Universitas Airlangga, Surabaya, Indonesia

WEDNESDAY 27 SEPTEMBER

DDD-040 Study on preparation of phencynonate hydrochloride extended release tablets and its pharmacokinetics in beagle dogs
Prof Hui Liu1, Ms. Yuan Zeng2, Ms. Yun Zhang3, Mr. Yan-chen Wang4, Mr. Xiang-yang Xie5
1Central Theater Command General Hospital, Wuhan, China, 2Central Theater Command General Hospital, Wuhan, China, 3The First People’s Hospital of Jiangxia Direct, Wuhan City, Wuhan, China, 4Xiangya Hospital Zhuzhou Central South University, Zhuzhou, China, 5Central Theater Command General Hospital, Wuhan, China

DDD-041 Physicochemical and microbiological stability of compounded clonidine hydrochloride oral liquid dosage forms in PCCA base, suspendIt
Dr Yashoda Pramar1, Dr. Tarun Mandal1, Dr. Levon Bostanian1, Ms. Jyra Johnson1, Mr. Richard Graves1
1Xavier University Of Louisiana College Of Pharmacy, New Orleans, United States

DDD-042 Formulation studies of instant herbal tea (Claritea®)
Ms Angeli Ann Rescober1, Mr Bryle Vince Briane Samson, Mr Joseph Dave Tuya
1Adamson University, Manila, Philippines

DDD-043 Inhalable ebselen dry powder for respiratory tract infections
Mr Tushar Saha1, Nikita Lyons2, Deborah Yung2, Dr Daniel Pletzer2, Professor Miguel E Quinones Mateu2, Associate Professor Shyamal Das1
1School of Pharmacy, University of Otago, Dunedin, New Zealand, 2Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand

DDD-044 Studies on novel intranasal delivery system of second generation antipsychotic drug
Ms Niserga Sawant1, Dr. Namita Desai2, Dr. Pratima Tatke3
1C.U.Shah College Of Pharmacy, S.N.D.T. Women’s University, Mumbai, India, 2C.U.Shah College Of Pharmacy, S.N.D.T. Women’s University, Mumbai, India, 3C.U.Shah College Of Pharmacy, S.N.D.T. Women’s University, Mumbai, India

DDD-045 Residence time of loratadine prolonged after intranasal administration of its gel formulation
Prof Gerard Lee Lo See1, Ms. Sophia Pagaran2, Ms. Bea May Remedio2, Ms. Kathrine Anne Flores1, Prof. Gea Abigail Ecoy1, Dr Florencio Jr Arce1
1Pharmaceutical Research and Drug Development Laboratories, Department of Pharmacy, School of Health Care Professions, University of San Carlos, Cebu, Philippines, 2Department of Pharmacy, School of Health Care Professions, University of San Carlos, Cebu, Philippines

DDD-046 Development and evaluation of microRNA-134 encapsulated cationic liposomes for chronic obstructive pulmonary disease.
Mr Rishi Mukesh Shah1, Matthew Reily-Bell2, Associate Professor Rajesh Katare2, Associate Professor Greg Walker1, Associate Professor Shyamal Das1
1School of Pharmacy, University of Otago, Dunedin, New Zealand, 2Department of Physiology, University of Otago, Dunedin, New Zealand

DDD-047 Analytical method development using LC/MS for SST01 oral formulation PK study
Dr Yunmei Song1, Dr Franklin Afinjuomo1, Ms Deepa Dadarao Nakmode1, Dr Stephen Page2, Professor Sanjay Garg1
1University of South Australia, Adelaide, Australia, 2Luoda Pharma, Newtown, Australia

DDD-048 Supersaturated solid self-nanoemulsifying drug delivery systems (Supersaturated S-SNEDDS) for the improved oral delivery of the poorly water-soluble and highly metabolised HIV antiretroviral, Lopinavir.
Ms Stephanie Stodulka1, Dr Hayley Schultz1, Dr Timothy Barnes1, Dr Paul Joyce1, Dr Clive Prestidge1
1University Of South Australia, Adelaide, Australia

DDD-049 A promising new oral delivery mode for insulin using lipid-filled enteric-coated capsules.
Dr Jamie Strachan1
1RMIT, Melbourne, Australia

DDD-050 The impact of iron on fatty acid trafficking across the blood-brain barrier
Mrs Showmika Tabassum Supti1, Dr Yijun Pan2, Dr Stephanie Newman1, Dr Liam Koehn1, Dr Joe Nicolazzo1
1Faculty of Pharmacy and Pharmaceutical sciences, Monash University, Parkville, Australia , 2Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Australia

DDD-051 Improvement skin penetration capacity of drug by using microemulsion as a delivery carrier: formulation optimization and in vitro evaluation
Mr Wen-Yu Chang1, Prof Paochu Wu1
1Kaohsiung Medical University, Kaohsiung City, Taiwan China

DDD-052 Efficient tumour targeted drug delivery via unidirectional transendothelial pathway mediated by Golgi apparatus
Ms Kaiyun Yang1,2, A/Prof Wenli Zhang1, Prof Zimei Wu2
1China Pharmaceutical University, Nanjing, China, 2University of Auckland, Auckland, New Zealand

DDD-053 Revolutionizing precision liver cancer treatment: Targeted and personalized chemotherapy delivery with biodegradable 3D printed bilayer films
Ms Souha Youssef1, Dr Raja Ganesan2, Mr Sangseo Kim1, Mr Sadikalmahdi Abdella1, Dr Franklin Afinjuomo1, Dr Yunmei Song1, Dr Nirmal Robinson2, Professor Sanjay Garg1
1Clinical & Health Sciences, University of South Australia, Adelaide, Australia, 2Centre for Cancer Biology, University of South Australia, Adelaide, Australia

DDD-054 Pharmacokinetic model for antibody-drug conjugates: An investigation of the properties of the linkers and the range of optimal cracking constants
Wang Zehua1
1中国药科大学, Nanjing, China

DDD-055 Framework nucleic acids loading siTNF-α for topical psoriasis treatment
Ms Yunfeng HAN1, Dr. Ying ZHENG1
1University Of Macau, Macau, Macau SAR China